Cairo – Mubasher: Egyptian International Pharmaceutical Industries Co. (EIPICO) posted a 24% rise in consolidated net profit for the first nine months of 2015 to EGP 312.8 million, taking into account minority interest, compared with EGP 252.5 million reported in the same period a year ago.
Meanwhile, the standalone financial results for the nine-month period showed 2639% growth in net profit to EGP 295.2 million, up from EGP 233.6 million.
